BR9809268A - Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona - Google Patents
Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolonaInfo
- Publication number
- BR9809268A BR9809268A BR9809268-5A BR9809268A BR9809268A BR 9809268 A BR9809268 A BR 9809268A BR 9809268 A BR9809268 A BR 9809268A BR 9809268 A BR9809268 A BR 9809268A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical dosage
- tibolone
- manufacturing
- carrier
- starch product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"UNIDADE DE DOSAGEM FARMACêUTICA, PROCESSO PARA FABRICAçãO DA MESMA, E, USO DE UM PRODUTO DE AMIDO COMO UM VEìCULO PARA UNIDADES DE DOSAGEM FARMACêUTICA COMPREENDENDO TIBOLONA". A invenção diz respeito a uma unidade de dosagem farmacêutica, tal como um tablete ou uma cápsula, compreendendo uma quantidade eficaz de tibolona (geralmente de 0,1 a 10% em peso) e um veículo farmaceuticamente aceitável contendo amido (também significado como granulado básico), em que o veículo contém de 10 a 100% em peso do amido. Assim uma formulação de tibolona mais estável é obtida, permitindo a armazenagem seca e doses mais baixas do ingrediente ativo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201180 | 1997-04-22 | ||
PCT/EP1998/002361 WO1998047517A1 (en) | 1997-04-22 | 1998-04-20 | Stabilized tibolone compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9809268A true BR9809268A (pt) | 2000-06-27 |
Family
ID=8228228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9809268-5A BR9809268A (pt) | 1997-04-22 | 1998-04-20 | Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona |
Country Status (26)
Country | Link |
---|---|
US (6) | US6399594B2 (pt) |
EP (1) | EP0975348B1 (pt) |
JP (1) | JPH10316573A (pt) |
KR (1) | KR100580855B1 (pt) |
CN (2) | CN1494908A (pt) |
AR (1) | AR012480A1 (pt) |
AT (1) | ATE281836T1 (pt) |
AU (1) | AU742037B2 (pt) |
BR (1) | BR9809268A (pt) |
CA (1) | CA2288070A1 (pt) |
DE (1) | DE69827484T2 (pt) |
DK (1) | DK0975348T3 (pt) |
ES (1) | ES2232949T3 (pt) |
HK (1) | HK1023508A1 (pt) |
HU (1) | HUP0001780A3 (pt) |
ID (1) | ID22763A (pt) |
IL (1) | IL123984A (pt) |
NO (1) | NO995127L (pt) |
NZ (1) | NZ338028A (pt) |
PL (1) | PL190227B1 (pt) |
PT (1) | PT975348E (pt) |
RU (1) | RU2207133C2 (pt) |
TR (1) | TR199902530T2 (pt) |
TW (1) | TW570798B (pt) |
WO (1) | WO1998047517A1 (pt) |
ZA (1) | ZA983169B (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100432093C (zh) | 1998-10-16 | 2008-11-12 | 欧加农股份有限公司 | 包含(7α,17α)-17-羟基-7-甲基-19-去甲-17-孕-5(10)-烯-20-炔-3-酮的高纯度组合物 |
CN1183904C (zh) * | 1999-02-26 | 2005-01-12 | 盐野义制药株式会社 | 改进了服用性的咀嚼型软胶囊剂及其制法 |
US20040229854A1 (en) * | 2000-11-28 | 2004-11-18 | Pieter Haan De | Immediate release dosage form for HRT |
PT1429802E (pt) * | 2001-09-28 | 2013-01-24 | Tntgamble Inc | Sistema de entrega para componente biológico |
US20070098784A1 (en) | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
GB0125061D0 (en) * | 2001-10-18 | 2001-12-12 | Norton Healthcare Ltd | Pharmaceutical composition |
TW200418525A (en) * | 2002-11-20 | 2004-10-01 | Akzo Nobel Nv | Coated pharmaceutical tablets containing Tibolone |
CN1324041C (zh) * | 2003-04-01 | 2007-07-04 | 上海迪赛诺医药科技开发有限公司 | 替勃龙晶型i的制备方法 |
ES2312996T3 (es) * | 2003-04-29 | 2009-03-01 | N.V. Organon | Proceso de solidificacion con antidisolvente. |
EP1499278B1 (en) * | 2003-05-23 | 2005-06-01 | Akzo Nobel N.V. | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
WO2005105278A2 (en) * | 2004-05-05 | 2005-11-10 | Akzo Nobel N.V. | Antisolvent emulsion solidification process |
WO2005117899A1 (en) * | 2004-06-02 | 2005-12-15 | Cipla Limited | Pharmaceutical composition comprising tibolone and process for procuding the same |
WO2005120517A1 (en) * | 2004-06-07 | 2005-12-22 | Strides Arcolab Limited | Stable liquid suspension formulation comprising synthetic steroids and process for producing the same |
CZ300465B6 (cs) * | 2007-07-25 | 2009-05-27 | Zentiva, A. S. | Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu |
CN102085193B (zh) * | 2009-12-08 | 2013-11-06 | 北京以岭生物工程技术有限公司 | 一种替勃龙口腔崩解片及其制备方法 |
CN104345098B (zh) * | 2013-08-05 | 2016-04-13 | 华润紫竹药业有限公司 | 一种测定替勃龙片剂中抗氧剂含量的方法 |
PL3452019T3 (pl) | 2016-05-04 | 2021-12-20 | Novalon S.A. | Zastosowanie alkoholi cukrowych w kompozycjach tybolonu |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4701450A (en) | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
CH676470A5 (pt) * | 1988-02-03 | 1991-01-31 | Nestle Sa | |
IE63051B1 (en) * | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
AU671706B2 (en) * | 1993-03-05 | 1996-09-05 | Akzo N.V. | Use of a Pregnane Derivative |
ATE227122T1 (de) | 1993-09-03 | 2002-11-15 | Smithkline Beecham Corp | Stabilisierte tablettenformulierung |
CA2159419C (en) * | 1994-10-17 | 2006-07-04 | Pieter De Haan | Solid pharmaceutical composition comprising an excipient capable of binding water |
-
1998
- 1998-04-07 IL IL12398498A patent/IL123984A/en active IP Right Grant
- 1998-04-15 ZA ZA983169A patent/ZA983169B/xx unknown
- 1998-04-20 US US09/403,139 patent/US6399594B2/en not_active Expired - Fee Related
- 1998-04-20 CN CNA2003101026335A patent/CN1494908A/zh active Pending
- 1998-04-20 DE DE69827484T patent/DE69827484T2/de not_active Expired - Fee Related
- 1998-04-20 PL PL98336658A patent/PL190227B1/pl not_active IP Right Cessation
- 1998-04-20 EP EP98928214A patent/EP0975348B1/en not_active Expired - Lifetime
- 1998-04-20 PT PT98928214T patent/PT975348E/pt unknown
- 1998-04-20 HU HU0001780A patent/HUP0001780A3/hu unknown
- 1998-04-20 CN CNB988044579A patent/CN1146424C/zh not_active Expired - Fee Related
- 1998-04-20 AT AT98928214T patent/ATE281836T1/de not_active IP Right Cessation
- 1998-04-20 RU RU99121407/14A patent/RU2207133C2/ru not_active IP Right Cessation
- 1998-04-20 KR KR1019997009726A patent/KR100580855B1/ko not_active IP Right Cessation
- 1998-04-20 TR TR1999/02530T patent/TR199902530T2/xx unknown
- 1998-04-20 AU AU80146/98A patent/AU742037B2/en not_active Ceased
- 1998-04-20 ID IDW991204A patent/ID22763A/id unknown
- 1998-04-20 DK DK98928214T patent/DK0975348T3/da active
- 1998-04-20 NZ NZ338028A patent/NZ338028A/en unknown
- 1998-04-20 BR BR9809268-5A patent/BR9809268A/pt not_active Application Discontinuation
- 1998-04-20 WO PCT/EP1998/002361 patent/WO1998047517A1/en not_active Application Discontinuation
- 1998-04-20 CA CA002288070A patent/CA2288070A1/en not_active Abandoned
- 1998-04-20 ES ES98928214T patent/ES2232949T3/es not_active Expired - Lifetime
- 1998-04-21 AR ARP980101819A patent/AR012480A1/es not_active Application Discontinuation
- 1998-04-22 JP JP10112312A patent/JPH10316573A/ja active Pending
- 1998-05-11 TW TW087107211A patent/TW570798B/zh not_active IP Right Cessation
-
1999
- 1999-10-21 NO NO995127A patent/NO995127L/no unknown
-
2000
- 2000-05-03 HK HK00102669A patent/HK1023508A1/xx not_active IP Right Cessation
-
2002
- 2002-04-08 US US10/117,899 patent/US6514958B1/en not_active Expired - Fee Related
- 2002-11-25 US US10/303,494 patent/US20030119801A1/en not_active Abandoned
-
2004
- 2004-01-08 US US10/754,733 patent/US20040142031A1/en not_active Abandoned
- 2004-01-08 US US10/754,732 patent/US20040142028A1/en not_active Abandoned
- 2004-01-08 US US10/754,685 patent/US20040142030A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809268A (pt) | Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona | |
DE69940557D1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
EP2269613A3 (en) | Solid orald dosage form comprising a combination of metformin and glibenclamide | |
PT91246A (pt) | Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo | |
NZ507566A (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
RU94046044A (ru) | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения | |
IL108071A0 (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them | |
UA35604C2 (uk) | Фармацевтична композиція з антидепресивною активністю | |
BR0211198A (pt) | Composições farmacêuticas e seu uso | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
EP0620004A4 (en) | MEDICAL COMPOSITION. | |
AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
KR970032872A (ko) | 아세틸살리실산을 함유하는 피부 손상 처치용 약물 | |
HUP9901303A2 (hu) | Gyógyszerkészítmény autoimmun betegségek kezelésére | |
GB2021409A (en) | Pharmaceutical composition | |
SE9403137D0 (sv) | Derivatives of carbohydrates and compositions containing them | |
AR019025A1 (es) | Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado | |
BR0012775A (pt) | Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido | |
FR2361110A1 (fr) | Medicaments anthelminthiques renfermant une association synergique de substances actives | |
ES2065855B1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
BR0010449A (pt) | 14beta-h-esteróis, composições farmacêuticas que compreendem os mesmos e uso destes derivados para a preparação de medicamentos reguladores da meiose | |
ATE335491T1 (de) | Arzneimittel gegen glomerulosclerose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, DESTA FORMA, COM BASE DOS ARTIGOS 8O, 11 E 13 DA LPI |